Macleods Pharmaceuticals Ltd — Pyrazinamide Exporter Profile
Indian Pharmaceutical Exporter · #2 for Pyrazinamide · $18.1M export value · DGFT Verified
Macleods Pharmaceuticals Ltd is the #2 Indian exporter of Pyrazinamide with $18.1M in export value and 361 verified shipments. Macleods Pharmaceuticals Ltd holds a 24.7% market share in Pyrazinamide exports across 84 countries.
Macleods Pharmaceuticals Ltd — Pyrazinamide Export Profile: Buyers & Destinations
Where Does Macleods Pharmaceuticals Ltd Export Pyrazinamide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $1.2M | 39 | 12.6% |
| NETHERLANDS | $1.2M | 54 | 11.9% |
| PAKISTAN | $623.0K | 15 | 6.4% |
| UNITED STATES | $418.6K | 24 | 4.3% |
| NIGERIA | $382.7K | 8 | 3.9% |
| RUSSIA | $350.0K | 7 | 3.6% |
| CAMBODIA | $300.0K | 6 | 3.1% |
| AFGHANISTAN | $298.0K | 9 | 3.1% |
| COTE D IVOIRE | $274.1K | 14 | 2.8% |
| KENYA | $257.7K | 8 | 2.6% |
Macleods Pharmaceuticals Ltd exports Pyrazinamide to 104 countries. The largest destination is SOUTH AFRICA accounting for 12.6% of Macleods Pharmaceuticals Ltd's Pyrazinamide shipments, followed by NETHERLANDS (11.9%) and PAKISTAN (6.4%). These destinations reflect Macleods Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Pyrazinamide from Macleods Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| I+SOLUTIONS | NETHERLANDS | $638.4K | 33 |
| MACLEODS PHARMACEUTICALS SA | SOUTH AFRICA | $565.0K | 16 |
| MACLEODS PHARMACEUTICALS SA (PTY) L | SOUTH AFRICA | $331.9K | 16 |
| MACLEODS PHARMA USA INC | UNITED STATES | $288.0K | 12 |
| NOUVELLE PSP CI | COTE D IVOIRE | $274.1K | 14 |
| IDA FOUNDATION | NETHERLANDS | $257.4K | 10 |
| ADVANCED PHARMACEUTICALS LIMITED | RUSSIA | $250.0K | 5 |
| IDA FOUNDATION, | NETHERLANDS | $237.7K | 9 |
| NATIONAL TB CONTROL PROGRAM,PAKISTA | PAKISTAN | $223.0K | 7 |
| NATIONAL TB CONTROL PROGRAMME, PAKI | PAKISTAN | $200.0K | 4 |
Macleods Pharmaceuticals Ltd supplies Pyrazinamide to 176 buyers globally. The largest buyer is I+SOLUTIONS (NETHERLANDS), followed by MACLEODS PHARMACEUTICALS SA (SOUTH AFRICA) and MACLEODS PHARMACEUTICALS SA (PTY) L (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Pyrazinamide Export Value and How Much Does Macleods Pharmaceuticals Ltd Contribute?
India exported $50.2M worth of Pyrazinamide through 1,459 shipments from 90 suppliers to 131 countries, serving 434 buyers globally. Macleods Pharmaceuticals Ltd contributes $18.1M to this total, accounting for 24.7% of India's Pyrazinamide exports. Macleods Pharmaceuticals Ltd ships Pyrazinamide to 104 countries through 176 buyers.
What Is the Average Shipment Value for Macleods Pharmaceuticals Ltd's Pyrazinamide Exports?
Macleods Pharmaceuticals Ltd's average Pyrazinamide shipment value is $50.0K per consignment, based on 361 shipments totaling $18.1M. The largest destination is SOUTH AFRICA (12.6% of Macleods Pharmaceuticals Ltd's Pyrazinamide exports).
How Does Macleods Pharmaceuticals Ltd Compare to Other Indian Pyrazinamide Exporters?
Macleods Pharmaceuticals Ltd ranks #2 among 90 Indian Pyrazinamide exporters with a 24.7% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($18.1M), LUPIN LIMITED ($16.1M), MACLEODS PHARMACEUTICALS LIMITED ($7.2M). Macleods Pharmaceuticals Ltd processed 361 shipments to 84 destination countries.
What Pyrazinamide Formulations Does Macleods Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| RIFAMPICIN 75MG/ISONIAZID 50MG/ PYRAZINAMIDE 150MG DISPERSIBLE TABLETS,PACK 63,975 (PACK SIZE 3 X 28 TABS)NOS | $150.0K | 3 |
| RIFAMPICIN 75MG/ISONIAZID 50MG/PYRAZINAMIDE 150MG DISPERSIBLE TABLETS BNO.NRU2449A, NRU2450A MD.11/24 ED.10/26 PS:3X28S | $150.0K | 3 |
| PATIENT KIT(FORECOX TRAC) (RIFAMPICIN 150MG+ISONIAZID 75MG+PYRAZINAMIDE 400MG+ETHAMBUTOL 275MG TABLETS USP)NOS | $150.0K | 3 |
| RIFAMPICIN 150MG/ ISONIAZID 75MG /PYRAZINAMIDE 400MG/ ETHAMBUTOL HCL 275MG TABLETS ( 3672 X 24 X28S) DRUGS AND PHARMACENOS | $150.0K | 3 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES RIFAMPICIN ISONIAZID AND PYRAZINAMIDE TABLETS (150MG+150MG+375 MG)NOS | $150.0K | 3 |
| MEDICINES. RIFAMPICIN 150MG + ISONIAZID 75MG + PYRAZINAMIDE 400MG + ETHAMBUTOL 275MG TABLETS | $150.0K | 3 |
| RIFAMPICIN 150MG/ISONIAZID 75MG/PYRAZINAMIDE 400/ETHAMBUTOL 275MG TABLET PS: 24X28S BNO:NRG23110C MD.12/23 ED.11/26**** | $146.5K | 3 |
| RIFAMPICIN 75MG / ISONIAZID 50MG / PYRAZINAMIDE 150MG DISPERSIBLE TABLETS | $144.0K | 3 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES RIFAMPICIN ISONIAZID PYRAZINAMIDE AND ETHAMBUTOL HYDROCHLORIDE TABLETS USP | $138.3K | 4 |
| RIFAMPICIN 75MG/ISONIAZID 50MG/PYRAZINAMIDE 150MG DISPERSIBLE TAB.,B/N:NRU2403A/NRU2405A/NRU2404A,M.D.JAN-24,E.D.DEC-25 | $132.7K | 3 |
Macleods Pharmaceuticals Ltd exports 333 distinct Pyrazinamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RIFAMPICIN 75MG/ISONIAZID 50MG/ PYRAZINAMIDE 150MG DISPERSIB with 3 shipments worth $150.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Pyrazinamide to Key Markets
What Macleods Pharmaceuticals Ltd must comply with to export Pyrazinamide to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Macleods Pharmaceuticals Ltd Compare to Nearest Pyrazinamide Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MACLEODS PHARMACEUTICALS LTD ★ | $18.1M | 361 | 84 | $50.0K |
| 1 | LUPIN LIMITED | $16.1M | 321 | 49 | $50.0K |
| 3 | MACLEODS PHARMACEUTICALS LIMITED | $7.2M | 143 | 51 | $50.0K |
Macleods Pharmaceuticals Ltd ranks #2 among 90 Indian Pyrazinamide exporters. Average shipment value of $50.0K compared to the market average of $557.3K. The closest competitors by value are LUPIN LIMITED and MACLEODS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Pyrazinamide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 357 | 24.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 170 | 11.7% |
| DELHI AIR | 154 | 10.6% |
| DELHI AIR CARGO ACC (INDEL4) | 126 | 8.6% |
| Bombay Air | 94 | 6.4% |
| NHAVA SHEVA SEA (INNSA1) | 87 | 6.0% |
| JNPT | 87 | 6.0% |
| JNPT/ NHAVA SHEVA SEA | 81 | 5.6% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pyrazinamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Pyrazinamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Macleods Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 504 individual customs records matching Macleods Pharmaceuticals Ltd exporting Pyrazinamide, covering 333 formulations to 104 countries via 176 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 131+ countries, 434+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Pyrazinamide Export Data from Macleods Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Macleods Pharmaceuticals Ltd's Pyrazinamide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Macleods Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Pyrazinamide Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Macleods Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pyrazinamide. For current shipment-level data, contact TransData Nexus.